A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction (Q44704627)
Jump to navigation
Jump to search
scientific article published in November 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction |
scientific article published in November 2003 |
Statements
1 reference
A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction (English)
1 reference
Fred Govier
1 reference
Axel-Juerg Potempa
1 reference
Joel Kaufman
1 reference
Jonathan Denne
1 reference
Pavel Kovalenko
1 reference
Sanjeev Ahuja
1 reference
1 November 2003
1 reference
1 reference
25
1 reference
11
1 reference
2709-2723
1 reference
Identifiers
1 reference
1 reference